Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/VIR/Revenue

Vir Biotechnology, Inc. (VIR) Revenue 2017–2025

Vir Biotechnology, Inc. (VIR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$68.6MFY2025 · since FY2017: $2.7M → $68.6M
171819202122232425
Fiscal yearValueYoY
FY2025$68.6M-7.6%
FY2024$74.2M-13.9%
FY2023$86.2M-94.7%
FY2022$1.6B+47.5%
FY2021$1.1B+1334.4%
FY2020$76.4M+843.9%
FY2019$8.1M-24.2%
FY2018$10.7M+293.9%
FY2017$2.7M—

Source: SEC XBRL filings · For reference only · Not investment advice

More VIR financial trends

VIR Net incomeVIR Net marginVIR Gross profitVIR Gross marginVIR Operating incomeVIR Operating marginVIR Operating cash flowVIR Free cash flowVIR Capital expendituresVIR Return on equityVIR Stock buybacksVIR Dividends paidVIR Total assetsVIR Total liabilitiesVIR Shareholders’ equityVIR overview →